{"organizations": [], "uuid": "34622af6bc98aa5d6f47dc1d2f90d50dba3755bb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/MedicalDeviceFinancing", "section_title": "Medical Device Financing from Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530573?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d%2520(%2540industries%253d%2522Medical%2520Devices%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "US", "title": "Discovery Labs nets $32.9mm through sale of Series A units", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Discovery Labs nets $32.9mm through sale of Series A units", "spam_score": 0.0, "site_type": "news", "published": "2015-07-23T02:40:00.000+03:00", "replies_count": 0, "uuid": "34622af6bc98aa5d6f47dc1d2f90d50dba3755bb"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530573?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d%2520(%2540industries%253d%2522Medical%2520Devices%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Discovery Labs nets $32.9mm through sale of Series A units", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Discovery Labs nets $32.9mm through sale of Series A units Deal Date: Jul-01-2015 / Deal # 201530573 Executive Summary \nDiscovery Laboratories Inc. (respiratory therapies) netted $32.9mm through the public sale of 16.3mm Series A units priced at $0.60. Each Series A unit consists of one common share and a seven-year Series A warrant to purchase one share exercisable at $0.70 per share. The company is also issuing investors, who after purchasing Series A units would own 10% or more of Discovery Labs, Series B units (a total of 42mm) at $0.60. Each B unit consists of one pre-funded seven year Series B warrant to buy one common share at an initial exercise price of $0.60, of which the entire amount will be pre-paid upon issuance of the Series B warrants, and one Series B warrant to purchase one share exercisable at $0.70.", "external_links": [], "published": "2015-07-23T02:40:00.000+03:00", "crawled": "2015-07-23T16:34:04.978+03:00", "highlightTitle": ""}